Efficacy of Xpert MTB/RIF assay in detecting Mycobacterium tuberculosis in samples with different results by smear and culture in a coastal city with high incidence of tuberculosis

被引:0
作者
Feng, Gang [1 ,2 ]
Jiang, Hongyu [1 ,2 ]
Chen, Ying [1 ]
机构
[1] Xuzhou Med Univ, Sch Med Technol, Xuzhou 221004, Peoples R China
[2] Fourth Peoples Hosp Lianyungang City, Lianyungang, Jiangsu Provinc, Peoples R China
关键词
Tuberculosis; Drug resistance; Xpert MTB/RIF; Diagnosis; PULMONARY TUBERCULOSIS; NEGATIVE PATIENTS; RISK-FACTORS; DIAGNOSIS; CARE; TRANSMISSION; RESISTANCE; ACCURACY;
D O I
10.1186/s12879-025-10446-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundTuberculosis (TB) is a global problem that seriously jeopardizes human health. Among them, the diagnosis and treatment of smear- or culture-negative TB patients is a challenge. The Xpert MTB/RIF (Xpert) assay has been reported to be a novel molecular diagnostic tool for rapidly detecting TB. Still, there is limited data on this assay's performance in subgroups of TB patients. This study aimed to evaluate the diagnostic value of the Xpert method in patients with different smear and culture results and to assess its efficacy for rifampicin resistance (RR) detection.MethodsWe retrospectively collected data from 1,721 patients with a clinical diagnosis of tuberculosis. Smear, Xpert, and traditional solid culture methods were used to detect TB infection and explore the detection rate of Xpert in the grouping of results from different smear and culture methods. Information on RR detected by the Xpert method and proportional method of drug sensitivity test (DST) was also recorded and kappa values, sensitivity, and specificity were calculated.ResultsWe observed that among the three methods, the Xpert method had the highest detection rate of 66.8%, followed by the culture method at 56.0% and the smear method had the lowest at 40.0%. The detection rate of Xpert was 98.3% (642/653) when both smear and culture were positive, 85.1% (296/348) when only one of the two methods, smear and culture, was positive, and 29.4% (212/720) when both smear and culture were negative. The Xpert method and DST showed a high agreement (kappa = 0.92) for RR detection. The highest mutation rate was observed for probe E (64.7%), and the least number of probe C mutations occurred (1.5%).ConclusionThe Xpert method has high detection efficiency. It has good diagnostic value in detecting MTB and RR, especially in cases where traditional culture and sputum smear results are negative, and significantly reduces the rate of missed diagnosis.
引用
收藏
页数:14
相关论文
共 57 条
  • [1] Diagnostic value of bronchoalveolar lavage in the subset of patients with negative sputum/smear and mycobacterial culture and a suspicion of pulmonary tuberculosis
    Ahmad, Mushtaq
    Ibrahim, Wanis H.
    Al Sarafandi, Sabir
    Shahzada, Khezar S.
    Ahmed, Shakeel
    Ul Haq, Irfan
    Raza, Tasleem
    Hameed, Mansoor Ali
    Thomas, Merlin
    Swehli, Hisham Ab Ib
    Sattar, Hisham A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 82 : 96 - 101
  • [2] Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia
    Alemu, Ayinalem
    Tadesse, Mengistu
    Seid, Getachew
    Mollalign, Helina
    Eshetu, Kirubel
    Sinshaw, Waganeh
    Abebaw, Yeshiwork
    Amare, Misikir
    Dagne, Biniyam
    Diriba, Getu
    Yenew, Bazezew
    Getu, Melak
    Zerihun, Betselot
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [3] [Anonymous], 2024, GLOBAL TUBERCULOSIS
  • [4] Comparison of microscopic and xpert MTB diagnoses of presumptive mycobacteria tuberculosis infection: retrospective analysis of routine diagnosis at Cape Coast Teaching Hospital
    Asare, Kwame Kumi
    Azumah, Daniel Edem
    Adu-Gyamfi, Czarina Owusua
    Opoku, Yeboah Kwaku
    Adela, Edward Morkporkpor
    Afful, Philip
    Abotsi, Godwin Kwami
    Abban, Ernest Awuakye
    Duntu, Paul Ekow
    Anyamful, Akwasi
    Moses, Alberta Bedford
    Botchway, Emmanuel
    Mwintige, Philimon
    Kyei, Samuel
    Amoah, Linda Eva
    Ekuman, Emmanuel Owusu
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [5] Prevalence of Multidrug-Resistant Tuberculosis and Associated Factors in Ethiopia: A Systematic Review
    Asgedom, Solomon Weldegebreal
    Teweldemedhin, Mebrahtu
    Gebreyesus, Hailay
    [J]. JOURNAL OF PATHOGENS, 2018, 2018
  • [6] Yield of Facility-based Targeted Universal Testing for Tuberculosis With Xpert and Mycobacterial Culture in High-risk Groups Attending Primary Care Facilities in South Africa
    Berhanu, Rebecca H.
    Lebina, Limakatso
    Nonyane, Bareng A. S.
    Milovanovic, Minja
    Kinghorn, Anthony
    Connell, Lucy
    Nyathi, Sipho
    Young, Katherine
    Hausler, Harry
    Naidoo, Pren
    Brey, Zameer
    Shearer, Kate
    Genade, Leisha
    Martinson, Neil A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 76 (09) : 1594 - 1603
  • [7] Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
    Byanyima, Patrick
    Kaswabuli, Sylvia
    Musisi, Emmanuel
    Nabakiibi, Catherine
    Zawedde, Josephine
    Sanyu, Ingvar
    Sessolo, Abdul
    Andama, Alfred
    Worodria, William
    Huang, Laurence
    Davis, J. Lucian
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [8] Missing men with tuberculosis: the need to address structural influences and implement targeted and multidimensional interventions
    Chikovore, Jeremiah
    Pai, Madhukar
    Horton, Katherine Chisholm
    Daftary, Amrita
    Kumwenda, Moses Kelly
    Hart, Graham
    Corbett, Elizabeth Lucy
    [J]. BMJ GLOBAL HEALTH, 2020, 5 (05):
  • [9] Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise
    Coussens, Anna K.
    Zaidi, Syed M. A.
    Allwood, Brian W.
    Dewan, Puneet K.
    Gray, Glenda
    Kohli, Mikashmi
    Kredo, Tamara
    Marais, Ben J.
    Marks, Guy B.
    Martinez, Leo
    Ruhwald, Morten
    Scriba, Thomas J.
    Seddon, James A.
    Tisile, Phumeza
    Warner, Digby F.
    Wilkinson, Robert J.
    Esmail, Hanif
    Houben, Rein M. G. J.
    [J]. LANCET RESPIRATORY MEDICINE, 2024, 12 (06) : 484 - 498
  • [10] Diagnostic performance analysis of Xpert MTB/RIF in lymph node tuberculosis: A retrospective study
    Dai, Lingshan
    Peng, Lijun
    Fang, Tingting
    Shao, Yanqin
    Cai, Long
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2024, 110 (01)